chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was incorrectly given 0.2mls of Pfizer gray cap instead of Pfizer orange cap. His family member was notified shortly after the shot was given, and advised to observe for any adverse effects.
My taste and smell have changed (not been lost).  Certain smells trigger a horrible smell to me now.  For example, I first noticed it with my shampoo. I started smelling a weird smell every time I washed my hair.  Then it got stronger and stronger as time went on and then also with other smells. It is an awful smell, but only triggered by certain things. I can smell other things just fine.  Also very similar to my taste. Some things taste horrible now. I can't eat peanut butter, orange juice, nuts, and then many foods taste just ok, and I part of it tastes ok, and part tastes horrible.  About a month after the first vaccine it was at it's peak and it has stayed the same since.
Developed a bitter taste in mouth ,tasted super bitter to cheescake,had an odd taste to it; This spontaneous case was reported by a health care professional and describes the occurrence of DYSGEUSIA (Developed a bitter taste in mouth ,tasted super bitter to cheescake,had an odd taste to it) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced DYSGEUSIA (Developed a bitter taste in mouth ,tasted super bitter to cheescake,had an odd taste to it). At the time of the report, DYSGEUSIA (Developed a bitter taste in mouth ,tasted super bitter to cheescake,had an odd taste to it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment to the events not provided.
itchy red spot at injection site 7-10 days after second injection  Persistant itchy red hives or blotches at injection site intermittantly for two months since second dose.
Bell's palsy; Hypoaesthesia; Injected limb mobility decreased; Muscular weakness; Paraesthesia; Injection site swelling; This regulatory authority case was reported by an other health care professional and describes the occurrence of BELL'S PALSY (Bell's palsy) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0352c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Meniere's disease. Concurrent medical conditions included Shellfish allergy, Bee sting, Drug allergy (aspirin), Penicillin allergy and Adhesive tape allergy. Concomitant products included IBUPROFEN, VITAMIN C [ASCORBIC ACID] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jun-2021, the patient experienced BELL'S PALSY (Bell's palsy) (seriousness criterion medically significant), HYPOAESTHESIA (Hypoaesthesia), INJECTED LIMB MOBILITY DECREASED (Injected limb mobility decreased), MUSCULAR WEAKNESS (Muscular weakness), PARAESTHESIA (Paraesthesia) and INJECTION SITE SWELLING (Injection site swelling). At the time of the report, BELL'S PALSY (Bell's palsy), HYPOAESTHESIA (Hypoaesthesia), INJECTED LIMB MOBILITY DECREASED (Injected limb mobility decreased), MUSCULAR WEAKNESS (Muscular weakness), PARAESTHESIA (Paraesthesia) and INJECTION SITE SWELLING (Injection site swelling) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jun-2021, Computerised tomogram head: abnormal (abnormal) diagnosed with bells palsy. On 19-Jul-2021, Computerised tomogram: abnormal (abnormal) abnormal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.  Patient was diagnosed with bells palsy and patient will see a neurologist.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt presented to ED 1/25/2021 with 1 week history of bilateral shoulder pain, started on right, left involved later, wore with movement. NKI. He was given IM ketorolac 30 mg and seen in Clinic by chiropractor with some relief  1 day. PT consult placed and is still pending. Known hx osteoarthritis right shoulder by x-ray 12/10/20  Pt returned to urgent care/walk-in clinic 2/8 with worsening bilateral shoulder pain.  ROM of both shoulders quite limited. NKI. Treated for PMR.
Information has been received from a medical assistant, for the GARDASIL, concerning a 33 year old female who on 16-SEP-2008 was vaccinated with the first dose of GARDASIL (Lot # 660620/0571X). There was no concomitant medication. It was subsequently learned that the patient was pregnant at the time of the above GARDASIL. The IMP was 25-AUG-2008. No adverse effects were reported. The patient sought unspecified medical attention. Follow-up information has been received from a health care professional who reported that concomitant therapy included PRENEXA and that the patient had a history of SINEQUAN use 2 years prior to pregnancy, 25 mg daily for depression. The patient did ultrasound on 21-OCT-2008, which showed estimated date of confinement on 03-JUN-2009 and additional ultrasounds occurred on 14-JAN-2009, 18-FEB-2009 and 14-MAY-2009. The MSAFP Test on 07-JAN-2009 showed negative. The Fetal Non-Stress test 2x per week starting from 32 showed reactive. On 25-MAY-2009 (38 weeks and 6 days from LMP) the patient with no previous pregnancy delivered a normal, healthy male baby weighing 7 pounds 15 ounces, Apgar score was 9/9. There was no congenital anomaly, other complication or abnormality. There were no infections, illnesses, or complications during pregnancy, however during pregnancy, however during labor/delivery the patient experienced failure to progress at 4cm, mild abruption during labor/delivery. No further information is available.
See attached forms: DD Form 2766C Vaccine Administration Record. Standard Form 600 Health Record Chronological; Record of Medical Care.
fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA. At the time of the report, PYREXIA outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       No relevant concomitant medication was reported. Treatment information were not provided.
Aches; Muscle pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PAIN (Aches), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). In April 2021, PAIN (Aches), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication and treatment information was reported. The patient stated that, she used to be active and pretty healthy.   This case was linked to MOD-2022-466170 (Patient Link).
Lump that has not gone away since April 20th.  Over 2 weeks. Muscle cramping and weakness.  Still tender to touch. Pain sometimes radiates up to neck and down to left hand. Sometimes numbness and tingling. Left hand and fingers cramp up when holding something where that has never happened before.   Can't sleep on my left side.
Pt devel weakness, loss of energy, h/a, migraine, arthralgia, intermitent fever, chills, & flushing starting 48 hrs post vax;
Soreness at injection site immediately post vaccination. This was followed by extreme joint pain the next day and back spasms, which persisted for multiple days. Developed a urinary tract infection within 24 hours of vaccination, which required treatment by primary care physician.
Covid arm, itchy raised rash around injection site. Appeared 7 dats after injection.
Pt reports tolerating well injection given at 9:00 a.m. HPV was given on same arm pt reports soreness of injection site
Lack of appetite, emesis x 2.  Previous injection given 10/2010, my son experienced same sxs one week after administration.
diarrhea,bodyache,chills. Pt reports loose stools starting 2100 last night, every 30 minutes, denies blood/mucus/pus. Pt received COVAX dose two yesterday.  CC: diarrhea, abdominal cramping  HPI: 24yo AD M presenting to ED with 1 day of the above symptoms. Pt received dose #2 of COVax yesterday then began having multiple bouts of watery diarrhea. He has no focal abdominal pain, no emesis, is PO tolerant. He has no dyspnea, no chest pain, no URI/LRI symptoms, no subjective focal neurologic deficits.
A non-serious spontaneous report of inadvertent administration of expired H1N1 LAIV was received from a registered nurse/health professional concerning an eight-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
Information has been received from the author (physician) of a published article, concerning a 48 year old female patient, who also was a nurse. The patient had documentation of receipt of 2 doses of MMR (manufacturer unknown) (lot #, dose, frequency and route not reported) in 1991 and 1992, respectively. In 2006, the patient had received negative measles immunoglobulin (Ig) G serology test results: however, according to recommendations of the Advisory Committee on Immunization Practices, she received two MMR (manufacturer unknown) doses. On 11-JAN-2015, the nurse had contact with a patient with laboratory-confirmed measles associated with an outbreak. On 21-JAN-2015, she developed a fever (103 F [39.4 C]), and on 23-JAN-2015 she experienced cough and coryza. On the same day, the nurse was identified as suspected measles. On 24-JAN-2015, she developed a rash. The patient was instructed to isolate herself at home. On 26-JAN-2015, serum, a nasopharyngeal swab, and a urine specimen were collected. The following day on 27-JAN-2015, measles infection was diagnosed by real time reverse transcription polymerase chain reaction testing of the nasopharyngeal swab and urine specimen and by detection of measles-specified IgM and IgG in serum by enzyme-linked immunosorbent assay. Because of her symptoms and laboratory results, the patient was considered to be infectious. The presence of measles IgG (index standard ratio=8.2, with more than or equal to 1.1 considered seropositive) 2 days after rash onset suggested secondary vaccine failure (waning of vaccine-induced immunity, rather than failure to develop an immune response to administered vaccine [i.e. primary vaccine failure]). The outcome of the events was unknown. The reporter considered events to be related to MMR (manufacturer unknown). Additional information has been requested.
This spontaneous report was received from a pharmacist of unknown age reporting on herself. The patient's concurrent conditions included hypercholesterolaemia, Sarcoidosis, sleep apnoea syndrome, hypertension, glucose tolerance impaired and hypothyroidism. On an unspecified date in 2005, the patient was vaccinated with PNEUMOVAX 23, intramuscularly (strength, dose number, lot number and expiration date were not provided) for prophylaxis. Then, on an unknown date in 2013 (reported as: "about 3 years ago"), she received a dose of ZOSTAVAX subcutaneously (strength, dose number, lot number and expiration date were not provided) for prophylaxis. Then, on an unknown date in August 2015, she received a dose of PREVNAR intramuscularly (strength, dose number, lot number and expiration date were not provided) for prophylaxis. On an unknown date in October 2016, the patient received a second dose of PNEUMOVAX 23.  Concomitant therapies included losartan potassium (manufacturer unknown), CRESTOR, LEVOXYL, liotrix, metoprolol and metformin. On an unspecified date in October 2016 (reported as: "On the same night that she received the most recent dose of PNEUMOVAX"), the patient experienced sore, painful, 2 inches diameter, raised, hard area at the site of the injection (Injection site pain and Injection site induration). It was reported that it made her miss work the next day. The patient took ibuprofen and TYLENOL for the pain on unspecified dates. On an unspecified date in 2016 (reported as: "About 2 to 3 days" after receiving this most recent PNEUMOVAX injection"), the patient recovered from the adverse events. The reporter did not assess the relatedness between the event and suspect therapy. Additional information has been requested. Sender's Comments: US-009507513-1612USA004758: US-009507513-1612USA005475: US-009507513-1612USA005476: US-009507513-1612USA005473: US-009507513-1612USA005474.
I've had chills; I want to sleep all the time/He is lethargic like he wants to sleep all the time; my mouth feels like it has cotton in it; tired; head feels strange/ He doesn't feel good/ He doesn't feel right; The temperature 100.1; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number EL3248, Expiration Date: unknown), via an unspecified route of administration, anatomical location-Left Arm On 29Jan2021 at single dose for COVID-19 immunization. The patient medical history included high blood pressure, High cholesterol, psoriasis. concomitant medication included Humira 2 days after the first vaccine dose in the belly.The patient experienced chills, lethargic, dry mouth, tired, feeling abnormal, the body temperature 100.1. The clinical course reported as 'He doesn't feel good. He had chills before the shot then he had more chills after the shot. He is lethargic like he wants to sleep all the time. He doesn't if know his immune condition psoriasis, for which he takes Humira has anything to do with it. He doesn't feel right, its the Pfizer BioNtech Covid Vaccine. He wants to know if this is a normal side effect. He has a Temperature of 100.1'. The patient underwent lab tests 03-FEB-2021 Blood test, Body temperature, 100.1, COVID-19 test result was negative. The outcome of event was unknown.  Follow up information completed. No further information is expected.
8 days after vaccination, a red, itchy bump, approximately 10x10 cm appeared.
Just sore on right arm, dizzy and headache, went to the walk in clinic, I was given a shot for my headache.
Pain in arm, shoulder, limited range of motion, difficulty sleeping due to shoulder pain in rotator cuff area.
On Tues the 19th I began to not be able to type on a computer or text on my phone. On Thurs the 21st I drove myself to the hospital. I had a horrible headache and was immediately checked in to the Emergency department at the hospital and an MRI was completed which discovered swelling on my brain. I was then admitted to the hospital and stayed there for 3 days until I was transferred to another hospital. I stayed there for 7 days and was given high doses of steroids to try and decrease the swelling in my brain. I was released and stayed out of work for 2 months. I still have swelling on my brain and I am still being monitored by the neurology department at the hospital.
Dizziness, Headache, Myalgia, Arthralgia, Fever, Night Sweats, Chills Narrative: Extreme headache, full body chills, fatigue, dizziness, extreme myalgia. Patient states 16 hours post vaccination, symptoms began and lasted for another 12 hours. Patient experienced severe night sweats.
1. Vomiting after vaccination     PLAN Discharge Medication List as of 12/28/2021 12:24 PM         COURSE & MEDICAL DECISION MAKING   Pt with h/o abdominal surgery, but no SBO Relays feeling unwell after covid booster yesterday No rooms available in ER, given PO zofran Feels much improved and wishes discharge but will return if vomiting returns Given take home pack Discharge Instructions    Please return if you are feeling unwell or continue to vomit   Discharge References/Attachments  Vomiting (Adult)
Itchy, painful red rash on left arm, measures 6 inches long by 2.5 inches wide
fainted before getting shot in the vaccination area brought to EMS via gurney and was given vaccine there on the gurney @ 9:09am. Tolerated well and was discharged in stable condition @ 930am.
I felt no effect at all throughout the day. About 1-2 hours after going to sleep, sometime around 12:30AM, I woke up with severe back pain, similar in feeling to a kidney stone. I was also involuntarily shaking from chills. I measured my temperature with a mouth thermometer at 102F. About 2 hours later I became delirious so I took a cold bath to bring the temperature down to 101F. I took 400mg Advil at 6:30AM as the fever still did not break.  The fever broke at about 10:00AM and I slept until about 3:00PM.  I continued to have body aches and a headache for another 6 hours, starting to feel normal at about 9:00PM.
Employee reported progressively worsening throat tightness after receiving flu vaccine.  Vaccine received at approximately 12:30pm on 9/8/09.  Sought treatment in ED at approx. 19:00 on 9/8/09.  C/o sx beginning approx 3.5hrs earlier, associated with burning eyes.  At time of ED tx sx assoc with difficulty breathing.  Tx with IV Solumedrol 125mg and IV Benadryl 25mg.  D/c home at 23:00 with report of improved sx.  D/c on Prednisone po and benadryl po prn
Fever; Chills; Aches and Pains; Lethargic; shaking; weakness; Sweats; joint pain; headache; pain in the armpit of the injection arm; severe sore throat; generally feeling ill; This is a spontaneous report from a contactable other healthcare professional. A 46-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3246; expiry date: unknown), intramuscular in the left arm on 08Jan2021 at 08:30, at a single dose, for COVID-19 immunisation. Medical history included autoimmune disease. The patient has no know allergies. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK5730; expiry date: unknown), intramuscular in the left arm on 18Dec2020 at 08:00 AM for COVID-19 immunisation. On 08Jan2021, at 15:00, the patient experienced fever, chills, aches and pains, lethargic, shaking, weakness, sweats, joint pain, headache, pain in the armpit of the injection arm, severe sore throat, and generally feeling ill. The patient did not receive treatment for the events. Outcome of the events was recovered. The patient underwent nasal swab on 10Jan2021 with a negative result.
Narrative:  88 y/o male w/ PMH of asthma, HTN, CAD, MDD, PTSD, GERD, BPH and OA. Pt presented to ED on 05/26/22 w/ COVID + several days ago while at facility, frequent falls, general fatigue & weakness. Pt admitted to hospital for sinus bradycardia. Pt treated for Rt knee pain-DJD, ESBL UTI, and COVID 19. Pt treated w/ remdesivir (05/27-05/31) and dexamethasone (05/27-06/02) for COVID 19. Pt improved and discharged to home on 06/15.
February 7 at 06:30PM and it went into injury areas. It went into my ankles (where I had had a previous injury)  and it went into my right wrist ( but not severe there). The pain in the ankles were 8  - this lasted for about 12 hours.  Symptoms went into chills. I had an elevated temp but not a fever, headache (horrible) and upset stomach and a bout of diarrhea. That took a couple of days for all the symptoms to disappear. No treatment. In Marchish, I had some bloating - stomach bloating and pain. That took me awhile to get into the doctor. I went in to the 1st time in April for this and he sent me to GI doctor. That was in May that I saw the GI doctor and I had to wait to July  to do endoscopy and colonoscopy.  June  15 2021 - ER visit They did an emergency appendectomy. Morning of 16th, they did surgery.  After the second vaccine, I not had a period since my second vaccine.
One week after receiving the vaccine I noticed arm felt sore again and itchy and a large red circular rash was on my arm
Wife called to report that her husband's arm has been sore/tender to the touch since getting the vaccine. He got a shingrix the same day on the other arm. It has been sore both on the top side and underneath in the arm pit. He doesn't have any sign of fever, redness, pain with shoulder movement or swelling. He is taking ibuprofen for the discomfort. Thinks there might be some improvement. Suggested it might be swelling of the lymph  nodes. Recommended to see a doctor if it gets worse or doesn't continue to improve.
expired dose administered to patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment products were reported. On 01-Dec-2021, the vial was initially stored in the refrigerator and was administered on 06-Jan-2022. Some patients had flu-like symptoms after receiving the vaccination but the reporter did not have details on that.
Difficulty breathing  Fatigue  Muscle or body aches  Headache  New loss of taste or smell  Sore throat  Congestion or running nose
This spontaneous report as received from a licensed practical nurse, refers to an unknown number of patients of unknown age and gender. On an unknown dates, the patients were inadvertently vaccinated with M-M-R II (lot #, expiration date, dose and route were not reported), that had been improperly stored. No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected, because there was no consent to contact a physician.